A carregar...
Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine
Neuroleptic malignant syndrome (NMS) is a relatively uncommon side effect that may develop after a recent increase in the therapeutic dose of an antipsychotic medication or the addition of a new agent in therapeutic doses. CASE REPORT: We report a case of NMS developing in a 36-year-old female patie...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer-Verlag
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3550334/ https://ncbi.nlm.nih.gov/pubmed/19191213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/BF03160978 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|